| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Charalabos Pothoulakis | |
| Kara J Gross | |||
| P2860 | cites work | Corticotropin releasing factor produces behavioural activation in rats. | Q51249282 |
| Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. | Q52235332 | ||
| Urocortin 2 suppresses host resistance to Listeria monocytogenes infection via up-regulation of interleukin-10. | Q53848645 | ||
| A study of the concentrations of substance p and neurotensin in the gastrointestinal tract of various mammals | Q53941817 | ||
| Potent Peripheral and Splanchnic Vasodilator Peptide from Normal Gut | Q59079149 | ||
| Molecular cloning of a functional human galanin receptor | Q24306226 | ||
| Long-term expression of corticotropin-releasing factor (CRF) in the paraventricular nucleus of the hypothalamus in response to an acute colonic inflammation | Q46901424 | ||
| Distribution of calcitonin gene-related peptide, somatostatin, substance P and vasoactive intestinal polypeptide in experimental colitis in rats | Q47715809 | ||
| Similar involvement of VIP receptor type I and type II in lymphocyte chemotaxis | Q47817699 | ||
| Human lymphocytes express substance P and its receptor | Q47877376 | ||
| Neuroimmune mechanisms of intestinal responses to stress. Role of corticotropin-releasing factor and neurotensin. | Q47966444 | ||
| Corticotropin-releasing hormone and inflammation | Q47966912 | ||
| Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice | Q48479409 | ||
| Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists | Q24310711 | ||
| Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBP beta is required for hepatocyte proliferation induced by TGF alpha | Q28142640 | ||
| International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands | Q28180444 | ||
| Cannabinoids and the gastrointestinal tract | Q28365382 | ||
| Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin | Q29617507 | ||
| Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease | Q30437360 | ||
| Psychological stress in IBD: new insights into pathogenic and therapeutic implications | Q30493180 | ||
| Neurotensin stimulates Cl(-) secretion in human colonic mucosa In vitro: role of adenosine | Q31423260 | ||
| Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease | Q33571955 | ||
| How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli | Q33815922 | ||
| Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum | Q33836192 | ||
| Axonal damage in Crohn's disease is frequent, but non-specific | Q34088771 | ||
| Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics | Q34141280 | ||
| Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells | Q34280805 | ||
| CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis | Q34327828 | ||
| Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes | Q34342202 | ||
| The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis | Q34350872 | ||
| Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation | Q34402440 | ||
| Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes | Q34597098 | ||
| Exploring the opioid system by gene knockout | Q34641459 | ||
| Psychoneuroimmunology: interactions between the nervous system and the immune system | Q34722770 | ||
| Review on the influence of stress on immune mediators, neuropeptides and hormones with relevance for inflammatory bowel disease | Q34759115 | ||
| Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-kappa B site on its promoter | Q34809257 | ||
| Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor | Q35044344 | ||
| VIP: a very important peptide in T helper differentiation | Q35124215 | ||
| The enteric nervous system II: gastrointestinal functions | Q35145421 | ||
| Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation | Q35361243 | ||
| Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells | Q35545383 | ||
| Changes in chemical coding of myenteric neurones in ulcerative colitis | Q35595304 | ||
| Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P | Q35660591 | ||
| Role of peripheral CRF signalling pathways in stress-related alterations of gut motility and mucosal function | Q35738979 | ||
| Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation. | Q35760524 | ||
| Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans | Q35769718 | ||
| Clinical relevance of advances in genetics and pharmacogenetics of IBD. | Q35787426 | ||
| Opioids as modulators of cell death and survival--unraveling mechanisms and revealing new indications | Q35866211 | ||
| Inflammatory bowel disease pathogenesis: therapeutic implications | Q36018544 | ||
| Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when | Q36036286 | ||
| Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats. | Q36147340 | ||
| The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications | Q36172911 | ||
| Without nerves, immunology remains incomplete -in vivo veritas | Q36257285 | ||
| Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease | Q36304141 | ||
| Ubiquitin protein modification and signal transduction: implications for inflammatory bowel diseases | Q36321691 | ||
| Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation | Q36548879 | ||
| A neurotensin antagonist, SR 48692, inhibits colonic responses to immobilization stress in rats | Q37243905 | ||
| Neurotensin Receptor and Its mRNA Are Expressed in Many Human Colon Cancer Cell Lines But Not in Normal Colonic Epithelium: Binding Studies and RT-PCR Experiments | Q38305175 | ||
| Regulation of nuclear factor-kappaB by corticotropin-releasing hormone in mouse thymocytes | Q38361525 | ||
| Enteric nervous system. I. Physiology and pathophysiology of the intestinal tract | Q38600542 | ||
| Gut-hormone profile in coeliac disease | Q39539213 | ||
| On the Mechanism of the Augmentation of the Phagocytic Capability of Phagocytic Cells by Tuftsin, Substance P, Neurotensin, and Kentsin and the Interrelationship between Their Receptors | Q40109677 | ||
| Neurotensin stimulates interleukin-8 expression through modulation of I kappa B alpha phosphorylation and p65 transcriptional activity: involvement of protein kinase C alpha. | Q40448923 | ||
| Metalloproteinase-dependent transforming growth factor-alpha release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells | Q40537038 | ||
| Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases | Q40711853 | ||
| Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes | Q40778287 | ||
| Role of CRF in stress-related alterations of gastric and colonic motor function | Q40788386 | ||
| Colonic vasoactive intestinal polypeptide in ulcerative colitis | Q40809714 | ||
| Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry | Q40831814 | ||
| Galanin causes Cl- secretion in the human colon. Potential significance of inflammation-associated NF-kappa B activation on galanin-1 receptor expression and function | Q40976259 | ||
| Increased substance P receptor expression by blood vessels and lymphoid aggregates in Clostridium difficile-induced pseudomembranous colitis | Q40980311 | ||
| Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides | Q41041826 | ||
| CRH and the immune system | Q41355419 | ||
| Crohn's disease: A scanning electron microscopic study | Q41448836 | ||
| Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation | Q41491272 | ||
| Beta-endorphin in the immune system: a role at last? | Q41546319 | ||
| Modulation of human natural killer activity by vasoactive intestinal peptide (VIP) family. VIP, glucagon and GHRF specifically inhibit NK activity | Q41635535 | ||
| Structure and functional expression of the cloned rat neurotensin receptor | Q41733457 | ||
| GAP-43 is expressed by nonmyelin-forming Schwann cells of the peripheral nervous system | Q41837595 | ||
| Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease | Q41980597 | ||
| Neuronal activity and CRF receptor gene transcription in the brains of rats with colitis | Q42462622 | ||
| Enteric glia | Q42470362 | ||
| Pivotal role of endogenous tachykinins and the NK1 receptor in mediating leukocyte accumulation, in the absence of oedema formation, in response to TNFalpha in the cutaneous microvasculature | Q42486141 | ||
| Galanin-1 receptor up-regulation mediates the excess colonic fluid production caused by infection with enteric pathogens | Q42492917 | ||
| Stimulation of connective tissue cell growth by substance P and substance K. | Q42815612 | ||
| The involvement of nitric oxide in the enhanced expression of mu-opioid receptors during intestinal inflammation in mice | Q43166827 | ||
| Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis. | Q43263394 | ||
| Antisense oligodeoxynucleotides to mu- and delta-opioid receptor mRNA block the enhanced effects of opioids during intestinal inflammation. | Q43846348 | ||
| Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease | Q44072241 | ||
| Corticotropin-releasing hormone antagonists possess anti-inflammatory effects in the mouse ileum | Q44081500 | ||
| Neuroimmunomodulation in inflammatory bowel disease. How far from "bench" to "bedside"? | Q44187222 | ||
| Effects of mu-opioid receptor agonists on intestinal secretion and permeability during acute intestinal inflammation in mice | Q44330488 | ||
| Characterization of Specific Opioid Binding Sites in Neural Membranes from the Myenteric Plexus of Porcine Small Intestine | Q44343165 | ||
| Opioid receptors on peripheral sensory axons | Q44346784 | ||
| Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease | Q44387835 | ||
| Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis. | Q45282194 | ||
| Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3. | Q45845617 | ||
| Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP. | Q46460985 | ||
| Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves protein kinase Cdelta activation | Q46510703 | ||
| Indiscriminate loss of myenteric neurones in the TNBS-inflamed guinea-pig distal colon | Q46632504 | ||
| P433 | issue | 7 | |
| P921 | main subject | inflammation | Q101991 |
| inflammatory bowel diseases | Q917447 | ||
| P304 | page(s) | 918-932 | |
| P577 | publication date | 2007-07-01 | |
| P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
| P1476 | title | Role of neuropeptides in inflammatory bowel disease | |
| P478 | volume | 13 |
| Q92156296 | A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases |
| Q35809350 | A role for corticotropin-releasing factor in functional gastrointestinal disorders |
| Q41816719 | Actions of probiotics on trinitrobenzenesulfonic acid-induced colitis in rats |
| Q34420848 | Adhesion GPCRs are widely expressed throughout the subsections of the gastrointestinal tract |
| Q36030894 | Adipose tissue and inflammatory bowel disease pathogenesis |
| Q51753894 | Alteration of neuromuscular transmissions in the hamster colon following the resolution of TNBS-induced colitis. |
| Q56986215 | An immunohistochemical study of the distribution of nitric oxide synthase-immunoreactive neurons and fibers in the reticular groove of suckling lambs |
| Q39901570 | An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. |
| Q36837922 | Anti-melanin-concentrating hormone treatment attenuates chronic experimental colitis and fibrosis. |
| Q33627796 | Application of Zebrafish Models in Inflammatory Bowel Disease |
| Q46072127 | Blockage of the neurokinin 1 receptor and capsaicin-induced ablation of the enteric afferent nerves protect SCID mice against T-cell-induced chronic colitis |
| Q90723386 | Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular Crosstalk |
| Q34746666 | Combined administration of secretin and oxytocin inhibits chronic colitis and associated activation of forebrain neurons |
| Q64105907 | Controlled-release neurotensin-loaded silk fibroin dressings improve wound healing in diabetic rat model |
| Q37871872 | Corticotrophin-releasing factor, related peptides, and receptors in the normal and inflamed gastrointestinal tract |
| Q35809342 | Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications |
| Q36465772 | Corticotropin-Releasing Hormone Receptor 2 Signaling Promotes Mucosal Repair Responses after Colitis |
| Q35203621 | Corticotropin-releasing factor signaling and visceral response to stress |
| Q34954885 | Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain |
| Q36713342 | Dual Role of Endogenous Serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis |
| Q28505064 | Expression and function of NIK- and IKK2-binding protein (NIBP) in mouse enteric nervous system |
| Q38622923 | Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease |
| Q38341386 | Identification and putative roles of distinct subtypes of intestinal dendritic cells in neuroimmune communication: what can be learned from other organ systems? |
| Q42252901 | Identification of a novel substance P (SP)-neurokinin-1 receptor (NK-1R) microRNA-221-5p inflammatory network in human colonic epithelial cells |
| Q43981293 | Immune modulation in gastrointestinal disorders: new opportunities for therapeutic peptides? |
| Q35857951 | Immunopathogenesis of IBD: current state of the art. |
| Q45327633 | Increased fecal levels of chromogranin A, chromogranin B, and secretoneurin in collagenous colitis. |
| Q37002385 | Inflammation and neuropeptides: the connection in diabetic wound healing |
| Q42754007 | Inhibition of vasoactive intestinal polypeptide (VIP) induces resistance to dextran sodium sulfate (DSS)-induced colitis in mice |
| Q35077963 | Intestinal upregulation of melanin-concentrating hormone in TNBS-induced enterocolitis in adult zebrafish |
| Q36802510 | Melanin-concentrating hormone as a mediator of intestinal inflammation. |
| Q38253468 | Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel. |
| Q39612931 | Molecular characterization of structure and tissue distribution of chicken neurotensin receptor |
| Q35061903 | Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome |
| Q36945717 | Neurochemical Plasticity of the Coeliac-Superior Mesenteric Ganglion Complex Neurons Projecting to the Prepyloric Area of the Porcine Stomach following Hyperacidity |
| Q53648903 | Neuroimmune interactions in patients with inflammatory bowel diseases: disease activity and clinical behavior based on Substance P serum levels. |
| Q37771058 | Neuroinflammation in inflammatory bowel disease |
| Q37208845 | Neurotensin induces IL-6 secretion in mouse preadipocytes and adipose tissues during 2,4,6,-trinitrobenzensulphonic acid-induced colitis |
| Q39497062 | Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors |
| Q37491434 | Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives |
| Q34171353 | Plasma hormones facilitated the hypermotility of the colon in a chronic stress rat model |
| Q47102131 | Profound loss of neprilysin accompanied by decreased levels of neuropeptides and increased CRP in ulcerative colitis. |
| Q35032821 | Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of pneumococcal meningitis |
| Q90094379 | Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions |
| Q36227327 | Protective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice |
| Q43088277 | Proteinase-activated receptors-1 and 2 induce electrogenic Cl- secretion in the mouse cecum by distinct mechanisms |
| Q82949838 | Recent insights into the integration of the intestinal epithelium within the mucosal environment in health and disease |
| Q26827692 | Role of enteric neurotransmission in host defense and protection of the gastrointestinal tract |
| Q33802982 | Role of far upstream element binding protein 1 in colonic epithelial disruption during dextran sulphate sodium-induced murine colitis |
| Q52611165 | Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. |
| Q43803974 | Role of miR-19a targeting TNF-α in mediating ulcerative colitis |
| Q59852872 | Role of neurokinin 1 receptors in dextran sulfate-induced colitis: studies with gene-deleted mice and the selective receptor antagonist netupitant |
| Q35590819 | Role of substance P in the regulation of glucose metabolism via insulin signaling-associated pathways |
| Q35815638 | Serum and colonic mucosal immune markers in irritable bowel syndrome |
| Q34231605 | Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors |
| Q36238054 | Substance P mediates pro-inflammatory cytokine release form mesenteric adipocytes in Inflammatory Bowel Disease patients |
| Q86009947 | Substance P- and choline acetyltransferase immunoreactivities in somatostatin-containing, human submucosal neurons |
| Q44330585 | Targeting opioid signaling in Crohn's disease: new therapeutic pathways |
| Q40566816 | The Gut's Little Brain in Control of Intestinal Immunity |
| Q26774660 | The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel Disease |
| Q34526079 | The Role of the Mesentery in Crohn's Disease: The Contributions of Nerves, Vessels, Lymphatics, and Fat to the Pathogenesis and Disease Course |
| Q84092360 | The role of transient receptor potential vanilloid 1 (TRPV1) receptors in dextran sulfate-induced colitis in mice |
| Q31119209 | Variant detection and runs of homozygosity in next generation sequencing data elucidate the genetic background of Lundehund syndrome |
| Q56992333 | What is the effect of inflammation on intestinal function? |
Search more.